INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 283 filers reported holding INTELLIA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.81 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,279,377 | -12.5% | 40,461 | +12.8% | 0.07% | -9.0% |
| Q2 2023 | $1,462,738 | +8.6% | 35,869 | -0.7% | 0.08% | -6.0% |
| Q1 2023 | $1,346,863 | +234.7% | 36,138 | +213.3% | 0.08% | +219.2% |
| Q4 2022 | $402,456 | -28.6% | 11,535 | +14.5% | 0.03% | -36.6% |
| Q3 2022 | $564,000 | +12.8% | 10,077 | +4.3% | 0.04% | +28.1% |
| Q2 2022 | $500,000 | -35.6% | 9,665 | -9.6% | 0.03% | -3.0% |
| Q1 2022 | $777,000 | -44.7% | 10,686 | -10.0% | 0.03% | -28.3% |
| Q4 2021 | $1,404,000 | -20.1% | 11,877 | -9.3% | 0.05% | -22.0% |
| Q3 2021 | $1,757,000 | +479.9% | 13,098 | +598.2% | 0.06% | +490.0% |
| Q2 2021 | $303,000 | – | 1,876 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Discovery Value Fund | 572,950 | $19,990,226 | 5.79% |
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,145,091 | $39,952,225 | 5.34% |
| MPM BioImpact LLC | 455,238 | $15,883,254 | 4.12% |
| ARK Investment Management | 9,420,782 | $328,691,084 | 2.85% |
| Atlas Venture Associates IX, LLC | 10,000 | $348,900 | 1.74% |
| Ghisallo Capital Management LLC | 250,000 | $8,722,500 | 1.55% |
| Nikko Asset Management Americas, Inc. | 2,976,002 | $103,743,430 | 1.49% |
| Prosight Management, LP | 72,116 | $2,516,127 | 1.37% |
| Rokos Capital Management LLP | 826,063 | $28,391,785 | 1.24% |
| Elmwood Wealth Management, Inc. | 67,899 | $2,368,996 | 1.18% |